ENTA
ENANTA PHARMACEUTICALS INC
Key Financials
Operating Income
$-85349000
↑ 29.9%
Net Income
$-81889000
↑ 29.4%
Revenue
$65.3M
↓ 3.4%
EPS (Diluted)
$-3.84
↑ 29.9%
Total Assets
$280.7M
↓ 25.5%
Cash & Equivalents
$32.3M
↓ 13.3%
Total Liabilities
$216.0M
↓ 12.8%
Shareholders' Equity
$64.7M
↓ 49.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
| 424B5 | 7/2/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| S-8 | 5/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENTA |
| Company Name | ENANTA PHARMACEUTICALS INC |
| CIK | 1177648 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| Phone | 617 607 0800 |